共 18 条
Pulmonary alveolar proteinosis - a rare pulmonary toxicity of sirolimus
被引:19
作者:
Pedroso, Sofia L.
[1
]
Martins, La Salete
Sousa, Sonia
Reis, Abilio
Dias, Leonidio
Henriques, Antonio C.
Sarmento, Antonio M.
Cabrita, Antonio
机构:
[1] Hosp Geral Santo, Dept Nephrol, P-4040011 Oporto, Portugal
[2] Hosp Geral Santo Antonio, Dept Transplant, Oporto, Portugal
[3] Hosp Geral Santo Antonio, Dept Internal Med, Oporto, Portugal
关键词:
immunosuppression;
kidney transplant;
pulmonary alveolar proteinosis;
rapamycin;
sirolimus;
D O I:
10.1111/j.1432-2277.2006.00408.x
中图分类号:
R61 [外科手术学];
学科分类号:
摘要:
The aim of our paper is to describe an unusual pulmonary toxicity of sirolimus (SRL) in a kidney transplant recipient. We present a 34-year-old woman with a second renal transplantation, complicated with steroid-resistant acute rejection and chronic allograft dysfunction. Two years after initiating SRL, she presented complaints of progressive dyspnoea, nonproductive cough, chest pain and low-grade fever of 1 month duration. She had chronic allograft nephropathy and slight elevation of lactic dehydrogenase levels. After exclusion of common reasons of this condition, a computed tomography (CT) of the thorax and bronchoscopy was performed, revealing ground-glass opacification with polygonal shapes on CT and an opaque appearance with numerous macrophages on bronchoalveolar lavage. The alveolar macrophages stained positive by Periodic acid-Schiff. Diagnosis of pulmonary alveolar proteinosis (PAP) was made and drug-induced toxicity was suspected. SRL was withdrawn with marked improvement in the patients' clinical and radiological status. PAP resolved within 3 months without further therapy. PAP is a very rare complication of SRL therapy with only a few cases described. Withdrawal of SRL with conversion to another immunosuppressant seems to be an appropriate procedure in this condition.
引用
收藏
页码:291 / 296
页数:6
相关论文